Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand

Fig. 3

Calibration plots. Assessment of the model’s internal validity using the development group (a), and external validity using the validation group (b): the mean predicted EGFR mutation probabilities plotted against the observed mutation probabilities with their 95% CI, shown in five groups created by the ranks of the predicted probabilities. Hosmer-Lemeshow test compares the observed and predicted probabilities: a p-value of > 0.05 indicates good calibration

Back to article page